DXE · Class II · 21 CFR 870.5150

FDA Product Code DXE: Catheter, Embolectomy

Leading manufacturers include Edwards Lifesciences and Edwards Lifesciences, LLC.

74
Total
74
Cleared
148d
Avg days
1976
Since
Growing category - 5 submissions in the last 2 years vs 0 in the prior period
Consistent review times: 164d avg (recent)

FDA 510(k) Cleared Catheter, Embolectomy Devices (Product Code DXE)

74 devices
1–24 of 74

About Product Code DXE - Regulatory Context

510(k) Submission Activity

74 total 510(k) submissions under product code DXE since 1976, with 74 receiving FDA clearance (average review time: 148 days).

Submission volume has increased in recent years - 5 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

FDA review times for DXE submissions have been consistent, averaging 164 days recently vs 147 days historically.

DXE devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →